With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
Immune checkpoint deficiency.
This look at 87 approved protocols assessing immune checkpoint inhibitors over the past 5 years reveals we’ve come a long way in the inclusion of populations with HIV when establishing safety and efficacy across countless indications for these new therapeutics. | Reuss, JAMA Netw Open 2020